Opening Comments |
8:00 am - 8:10 am
|
Overall Welcome
|
Robin R. Young, CFA
President and Publisher
RRY Publications
PearlDiver Data, Inc.
|
8:12 am - 8:32 am
|
The Art and Science of Stem Cell Therapies
|
Arnold I. Caplan, PhD
Professor of Biology and
General Medicine Sciences (Oncology)
Case Western Reserve University
|
| |
Cardiovascular |
8:34 am - 8:44 am |
Harvest Technologies Corp. |
Gary D. Tureski, Co-Founder & President
|
8:46 am - 8:56 am
|
Cytori Therapeutics , Inc. |
ChristopherJ. Calhoun, MBA
Co-Founder &
CEO
|
8:58 am - 9:08 am
|
Bioheart, Inc. |
Howard J. Leonhardt, Founder
Executive Chairman & CTO
|
9:10 am - 9:20 am
|
Arteriocyte, Inc. |
Vincent Pompili , CEO
Chief Medical Officer
|
9:22 am - 9:32 am
|
Athersys, Inc. |
William (BJ) Lehmann,
President & COO
|
9:34 am - 9:44 am
|
Gamida Cell Ltd. |
Yael Margolin, PhD, CEO
|
9:46 am - 9:56 am
|
Aastrom Biosciences, Inc. |
Sheldon Schaffer, PhD,
VP, Corporate Development
& Intellectual Property
|
9:58 am - 10:08 am
|
Geron Corp. |
Jane S. Lebkowski, PhD,
Sr. VP - Regenerative Medicine |
| |
| Autoimmune and Anti-Inflammatory |
10:10 am - 10:20 am
|
Osiris Therapeutics, Inc. |
C. Randal Mills, PhD
President, CEO & Director
|
10:22 am - 10:32 am
|
Genzyme Corporation |
Stephen W. Potter, Sr., Vice President
|
10:34 am - 10:44 am
|
Progenitor Cell Therapy, Inc. |
Robert A. Preti, PhD,
President and Chief Scientific Officer
|
| |
20-Minute Break
|
| |
| Hematology / Oncology |
11:04 am - 11:14 am
|
Cleveland BioLabs, Inc. |
Michael Fonstein, PhD,
President & CEO
|
11:16 am - 11:26 am
|
Aldagen, Inc. |
Ed Field, President & COO
|
11:28 am - 11:38 am
|
INCELL Corp. |
Mary Pat Moyer, PhD
Founder, President, CEO &
Chief Science Officer
|
11:40 am - 11:50 am
|
AllCells, LLC |
Eric Martinelli ,
Business Development Manager
|
11:52 am - 12:02 pm
|
BioE Corp. |
Michael Haider, President & CEO
|
12:04 pm - 12:14 pm
|
MaxCyte, Inc. |
Madhusudan V. Peshwa, PhD,
VP - Research & Development
|
| |
|
Luncheon Keynote Speakers |
12:30 pm - 12:50 pm |
Wise Young, MD, PhD, Professor II
Richard H. Shindell Chair in Neuroscience
Founding Director, W.M. Keck Center for Collaborative Neuroscience
Rutgers, The State University of New Jersey
|
12:55 pm - 1:15 pm |
Thomas R. Lyon, MD
Chief of Orthopaedic Surgery
Asst. Professor Orthopaedic Surgery
Lutheran Medical Center
|
| |
| Musculoskeletal |
1:30 pm - 1:40 pm
|
3DM Inc. |
Zen Chu, President & Co-Founder
|
1:42 pm - 1:52 pm
|
SpineSmith Partners |
Robert Johnson, MD
|
1:54 pm - 2:04 pm
|
Blackstone Medical /
Orthofix International
|
Raymond J. Linovitz, MD, FACS
Medical Director
|
2:06 pm - 2:16 pm
|
MesoBlast Limited |
Silviu Itescu, PhD
Founder & Chief Scientific Officer
|
2:18 pm - 2:28 pm
|
TiGenix NV |
Luc Dochez, VP Business Development
|
| |
| Neurology / Nerve Repair and Regeneration |
2:30 pm - 2:40 pm
|
PrimeGen Biotech LLC |
John S. Sundsmo, President |
2:42 pm - 2:52 pm
|
StemCyte Inc. |
Kenneth J. Giacin, Chairman & CEO
|
2:54 pm - 3:04 pm
|
Stemagen |
Samuel H. Wood, MD, PhD
CEO
|
3:06 pm - 3:16 pm
|
Tissue Genesis, Inc. |
Stuart Williams, PhD
Chief Science Officer
|
3:18 pm - 3:28 pm
|
Regenetech, Inc. |
David C. Bonner, PhD
Chairman & CEO
|
3:30 pm - 3:40 pm
|
Neuronyx, Inc. |
Anne Faulkner Schoemaker, CEO
|
3:42 pm - 3:52 pm
|
ReNeuron Group |
Michael Hunt,
CEO
|
| |
Mid-Afternoon Break
|
| |
| Expanding the Range of Stem Cell Therapies |
4:02 pm - 4:12 pm
|
Vet-Stem, Inc. |
Robert J. Harman, DVM, MPVM
CEO & Founder
|
4:14 pm - 4:24 pm
|
Stemina, Inc. |
Gabriela Cezar, DVM, PhD
Chief Scientific Officer |
4:26 pm - 4:36 pm
|
Cognate BioServices, Inc. |
Aaron H. Heifetz , PhD
VP Business Development |
4:38 pm - 4:48 pm
|
VistaGen Therapeutics, Inc. |
H. Ralph Snodgrass, PhD
President & CEO
|
4:50 pm - 5:00 pm
|
Novocell, Inc. |
Alan J. Lewis, PhD
President, CEO & Director
|
5:02 pm - 5:12 pm
|
NeoStem, Inc. |
Robin Smith, PhD
President & CEO
|
| |
5:15 pm - 5:30 pm |
New York's Lt. Gov. David A. Paterson |
5:32 pm - 5:42 pm |
Closing Remarks
"Problems, Challenges and Promises"
Robin R. Young, CFA
|
| |
5:45 pm - 7:00 pm Reception and Networking
|
| |